FDA.reportPublic FDA data

Application 050703

Type
NDA
Sponsor
GLAXOSMITHKLINE

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001BACTROBANMUPIROCIN CALCIUMOINTMENT;NASALEQ 2% BASEYesNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
0029-1526BACTROBANmupirocin calciumGlaxoSmithKline LLCNDACurrent
0029-1526BACTROBANmupirocin calciumGlaxoSmithKline LLCNDACurrent
0029-1526BACTROBANmupirocin calciumGlaxoSmithKline LLCNDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
61922SUPPL2020-02-20
61926SUPPL2020-02-19
48345SUPPL2017-05-10
48317SUPPL2017-05-09
18042SUPPL2015-05-21
8035SUPPL2015-05-19
39135SUPPL2014-05-28
8034SUPPL2014-05-27